syndrome	score	normalized_score
PHACE ASSOCIATION	2.5	100.0
STURGE-WEBER SYNDROME	2.25	90.0
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	2.04170431	81.6681724
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	1.63034111	65.2136444
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	1.5909091	63.636364
MARTINEZ-FRIAS SYNDROME	1.5	60.0
#600803 GALLBLADDER DISEASE 1; GBD1;;CHOLELITHIASIS, LOW PHOSPHOLIPID-ASSOCIATED; LPAC	1.3060683000000002	52.242732000000004
SECKEL SYNDROME 10; SCKL10	1.2688679	50.754716
HEPATOCELLULAR CARCINOMA	1.2016805	48.06722
ALAGILLE SYNDROME 1; ALGS1	1.1773601200000001	47.09440480000001
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	1.135	45.4
METACHROMATIC LEUKODYSTROPHY	1.125	45.0
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	1.1200395699999999	44.80158279999999
#615207 IL21R IMMUNODEFICIENCY	1.1151515	44.60606
SILVER-RUSSELL SYNDROME; SRS	1.108274	44.33096
CRANIOECTODERMAL DYSPLASIA 1	1.09219784	43.68791360000001
Congenital disorder of glycosylation, type IIh	1.08659033	43.4636132
MECKEL SYNDROME, TYPE 6; MKS6	1.0788114	43.152456
WILSON DISEASE	1.0771597099999999	43.0863884
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	1.03880937	41.5523748
CHOLESTASIS-LYMPHEDEMA SYNDROME	1.03614871	41.4459484
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	1.02986511	41.1946044
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	1.0188679	40.754716
MEVALONIC ACIDURIA; MEVA	1.0188015	40.75205999999999
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	1.01099721	40.4398884
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	1.01	40.400000000000006
DIAPHANOSPONDYLODYSOSTOSIS	1.00325733	40.1302932
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	1.00318471	40.127388399999994
ANGIOMA, TUFTED	1.0	40.0
DIAMOND-BLACKFAN ANEMIA 11; DBA11	1.0	40.0
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	1.0	40.0
CAYLER CARDIOFACIAL SYNDROME	1.0	40.0
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.0	40.0
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	1.0	40.0
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	1.0	40.0
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	1.0	40.0
CARDIAC-UROGENITAL SYNDROME; CUGS	1.0	40.0
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	1.0	40.0
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	1.0	40.0
CARNEY-STRATAKIS SYNDROME	1.0	40.0
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	1.0	40.0
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	1.0	40.0
CHOLANGIOCARCINOMA	1.0	40.0
HEPATIC ADENOMAS, FAMILIAL	1.0	40.0
PALLISTER-HALL SYNDROME	1.0	40.0
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	1.0	40.0
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	1.0	40.0
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.8365903299999999	33.4636132
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.83651771	33.4607084
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.77818471	31.1273884
PETERS-PLUS SYNDROME; PTRPLS	0.65483679	26.193471599999995
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.63599721	25.4398884
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.6250376100000001	25.00150440000001
LATHOSTEROLOSIS	0.61940313	24.776125200000003
MITCHELL-RILEY SYNDROME; MTCHRS	0.6166670000000001	24.666680000000003
HALOTHANE HEPATITIS	0.61	24.4
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.60900901	24.360360399999998
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.6011458000000001	24.045832000000004
IMMUNE DEFICIENCY DISEASE	0.6	24.0
BARE LYMPHOCYTE SYNDROME, TYPE II	0.6	24.0
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5933333000000001	23.733332
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.56114871	22.4459484
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.5447537599999999	21.790150399999995
SPLENOPORTAL VASCULAR ANOMALIES	0.5384073	21.536292000000003
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.5320509299999999	21.282037199999998
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.53125	21.25
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.52833621	21.1334484
SCLEROSING CHOLANGITIS, NEONATAL	0.52821171	21.1284684
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.52503761	21.0015044
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.5188015	20.75206
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.5151515	20.60606
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.51219372	20.4877488
GLYCOGEN STORAGE DISEASE VI	0.51099721	20.4398884
LAMBERT SYNDROME	0.51	20.400000000000002
FRYNS SYNDROME; FRNS	0.5070922	20.283687999999998
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.5070448299999999	20.281793199999996
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.50675676	20.2702704
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.50325733	20.1302932
GLYCOGEN STORAGE DISEASE IXB	0.50318471	20.127388399999997
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.50318471	20.127388399999997
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.50318471	20.127388399999997
MENTAL RETARDATION, BUENOS AIRES TYPE	0.5	20.0
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.5	20.0
SPONDYLOPERIPHERAL DYSPLASIA	0.5	20.0
#234810 PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2;;HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	0.5	20.0
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.5	20.0
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.5	20.0
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.5	20.0
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.5	20.0
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.5	20.0
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5	20.0
APOLIPOPROTEIN A-I; APOA1	0.5	20.0
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.5	20.0
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.4938260099999999	19.753040399999996
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.4819807	19.279228
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.47997071	19.1988284
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.47190840999999994	18.8763364
ROBERTS SYNDROME; RBS	0.458333	18.33332
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.4570922	18.283688
FRONTOOCULAR SYNDROME	0.42654685000000003	17.061874000000003
FIBROSCLEROSIS, MULTIFOCAL	0.4242421	16.969684
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.41681976000000004	16.6727904
GLYCOGEN STORAGE DISEASE IB	0.40315371	16.1261484
GLYCOGEN STORAGE DISEASE IA	0.40315371	16.1261484
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.40171893999999997	16.0687576
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.39947952000000003	15.9791808
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.39336441	15.7345764
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.38447950000000003	15.37918
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.38447950000000003	15.37918
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.37503760999999997	15.001504399999998
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.35639756	14.2559024
AYME-GRIPP SYNDROME; AYGRP	0.35261372	14.1045488
CAROLI DISEASE, ISOLATED	0.35080371	14.0321484
HEMIFACIAL MICROSOMIA	0.349206	13.968240000000002
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.3484845	13.939379999999998
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.3484845	13.939379999999998
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.3476187	13.904748
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.34651771	13.8607084
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.34368253	13.7473012
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.3388114	13.552456
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.333333	13.333319999999999
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.333333	13.333319999999999
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.333333	13.333319999999999
HYPERCALCEMIA, INFANTILE, 1	0.333333	13.333319999999999
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.333333	13.333319999999999
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.333333	13.333319999999999
#610896 BRANCHIOOTORENAL SYNDROME 2; BOR2	0.333333	13.333319999999999
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.333333	13.333319999999999
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.333333	13.333319999999999
%109500 BASILAR IMPRESSION, PRIMARY	0.333333	13.333319999999999
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.333333	13.333319999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.333333	13.333319999999999
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.333333	13.333319999999999
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.31841882	12.736752800000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.31659434	12.6637736
HEMOCHROMATOSIS, NEONATAL	0.3163684	12.654736
LIVER FAILURE, INFANTILE, TRANSIENT	0.31056182	12.4224728
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.30685991	12.2743964
NAVAJO NEUROHEPATOPATHY	0.29462701	11.7850804
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.291667	11.66668
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.29	11.6
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.2884615	11.538459999999999
ALSTROM SYNDROME; ALMS	0.27986511	11.1946044
ARGININOSUCCINIC ACIDURIA	0.27644051000000003	11.057620400000001
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.2737684	10.950736000000001
ADAMS-OLIVER SYNDROME 5; AOS5	0.2727273	10.909092000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.27022258000000005	10.808903200000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.265873	10.634920000000001
BOHRING-OPITZ SYNDROME	0.26555109000000005	10.622043600000001
118900 CIRRHOSIS, FAMILIAL	0.2651515	10.60606
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.26424633000000003	10.5698532
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.26353424	10.5413696
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.26318471	10.5273884
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.26200821	10.480328400000001
AICARDI SYNDROME; AIC	0.2613275	10.4531
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.26116320000000004	10.446528000000002
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.26034953	10.4139812
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.25987985	10.395194
CHROMOSOME 16p13.3 DELETION SYNDROME	0.25675676	10.2702704
MICROCEPHALY, AUTOSOMAL DOMINANT	0.25662252	10.264900800000001
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.25662252	10.264900800000001
BRANCHIOOCULOFACIAL SYNDROME	0.25662252	10.264900800000001
HEMANGIOMAS OF SMALL INTESTINE	0.25	10.0
#614379 COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD ;;C4B DEFICIENCY	0.25	10.0
AXIAL OSTEOMALACIA	0.25	10.0
HYPERPARATHYROIDISM 2	0.25	10.0
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.25	10.0
DYSTONIA 6, TORSION	0.25	10.0
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.25	10.0
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.25	10.0
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.25	10.0
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.25	10.0
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	10.0
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	10.0
TRANSALDOLASE DEFICIENCY	0.24316530999999997	9.726612399999999
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.24182754000000004	9.673101600000003
NEPHRONOPHTHISIS 18; NPHP18	0.23448280000000002	9.379312
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.22272730000000002	8.909092000000001
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.22205261	8.8821044
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.21179964	8.471985600000002
BECKWITH-WIEDEMANN SYNDROME	0.21027691	8.4110764
LEIGH SYNDROME; LS	0.20900901000000002	8.360360400000001
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.20325733	8.1302932
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.20318471000000002	8.127388400000001
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.20318471000000002	8.127388400000001
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.20318471000000002	8.127388400000001
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.20318471000000002	8.127388400000001
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.20318471000000002	8.127388400000001
#604901 NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	0.2022083	8.088332000000001
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	0.2	8.0
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.2	8.0
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.2	8.0
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.2	8.0
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.2	8.0
HARDIKAR SYNDROME	0.19134351000000002	7.6537404
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.18977580000000002	7.591032
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.1885196	7.540784
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.18624606000000002	7.4498424000000005
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.17825733000000002	7.130293200000001
%300712 CRANIOFACIOSKELETAL SYNDROME	0.177656	7.10624
ALAGILLE SYNDROME 2	0.177656	7.10624
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.17500000000000002	7.000000000000001
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.17500000000000002	7.000000000000001
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.17500000000000002	7.000000000000001
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.17500000000000002	7.000000000000001
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.1744795	6.97918
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.17167652000000003	6.867060800000001
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.16992433	6.7969732
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.16992433	6.7969732
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.166667	6.6666799999999995
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.166667	6.6666799999999995
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.166667	6.6666799999999995
#602089 HEMANGIOMA, CAPILLARY INFANTILE;;HCI;;HEMANGIOMA, HEREDITARY CAPILLARY	0.166667	6.6666799999999995
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.166667	6.6666799999999995
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.166667	6.6666799999999995
CRANIOLENTICULOSUTURAL DYSPLASIA	0.166667	6.6666799999999995
184705 STEINFELD SYNDROME	0.166667	6.6666799999999995
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.166667	6.6666799999999995
#615721 RENAL HYPODYSPLASIA/APLASIA 2; RHDA2	0.166667	6.6666799999999995
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.15988611000000005	6.395444400000002
CHARGE SYNDROME	0.15872999999999998	6.3492
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.15318471000000003	6.127388400000002
CIRRHOSIS, FAMILIAL	0.152857	6.11428
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.15199421000000002	6.079768400000001
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.15066949999999998	6.02678
BARDET-BIEDL SYNDROME 1; BBS1	0.1482558	5.930232
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.1481749	5.926996
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.1464647	5.858588
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.14285699999999998	5.71428
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.14285699999999998	5.71428
STUVE-WIEDEMANN SYNDROME	0.14285699999999998	5.71428
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.14285699999999998	5.71428
MENTAL RETARDATION, X-LINKED 2	0.14285699999999998	5.71428
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.13853424	5.5413695999999995
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.1376582	5.506328000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.13719372000000002	5.487748800000001
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.13654012000000001	5.461604800000001
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.13651801000000002	5.4607204000000005
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.1363636	5.454544
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.13599721	5.4398884
DUBIN-JOHNSON SYNDROME	0.135	5.4
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.1328125	5.3125
REYNOLDS SYNDROME	0.13210821	5.284328400000001
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.12825733	5.1302932000000006
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.12825733	5.1302932000000006
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.1266804	5.067216
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.12654009	5.0616036
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.1262946	5.0517840000000005
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.125	5.0
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.125	5.0
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.125	5.0
PEUTZ-JEGHERS SYNDROME	0.125	5.0
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.1212121	4.848484
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.11999801	4.7999204
TRICHOHEPATOENTERIC SYNDROME 2	0.11833621	4.7334483999999994
#615395 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	0.11682151	4.6728604
NEPHRONOPHTHISIS 19; NPHP19	0.11647890999999999	4.6591564
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.11318471	4.5273884
COACH SYNDROME	0.11130920999999999	4.452368399999999
BILIARY CIRRHOSIS, PRIMARY	0.11111099999999999	4.444439999999999
CYSTIC FIBROSIS	0.11111099999999999	4.444439999999999
DUBOWITZ SYNDROME	0.11003943000000001	4.4015772
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.10980722999999999	4.3922892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.10900901	4.3603604
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.1078125	4.3125
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.10662252	4.2649008
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.10662252	4.2649008
OROFACIODIGITAL SYNDROME I; OFD1	0.10488613	4.1954452
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.1035673	4.142692
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.10318471	4.1273884
HEPATITIS B VACCINE, RESPONSE TO	0.1	4.0
#613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY	0.1	4.0
PSORIASIS 14, PUSTULAR	0.1	4.0
219400 CYANOSIS AND HEPATIC DISEASE	0.1	4.0
3MC SYNDROME 1	0.1	4.0
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.1	4.0
3MC SYNDROME 3	0.1	4.0
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.1	4.0
3MC SYNDROME 2	0.1	4.0
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.1	4.0
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.09848480000000001	3.9393920000000007
WARSAW BREAKAGE SYNDROME; WABS	0.09416643000000001	3.7666572
LOEYS-DIETZ SYNDROME 5	0.09415587	3.7662348
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.0909091	3.6363640000000004
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0909091	3.6363640000000004
MELNICK-NEEDLES SYNDROME	0.0909091	3.6363640000000004
RCAD (renal cysts and diabetes)	0.0909091	3.6363640000000004
LARON SYNDROME	0.0909091	3.6363640000000004
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	3.6363640000000004
THANATOPHORIC DYSPLASIA, TYPE I	0.0909091	3.6363640000000004
ATRANSFERRINEMIA	0.0909091	3.6363640000000004
THANATOPHORIC DYSPLASIA, TYPE II	0.0909091	3.6363640000000004
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.0909091	3.6363640000000004
CAMPOMELIC DYSPLASIA	0.0909091	3.6363640000000004
SITOSTEROLEMIA	0.0909091	3.6363640000000004
IMMUNODEFICIENCY 47	0.08849491	3.5397963999999997
GLYCOGEN STORAGE DISEASE IV	0.0877705	3.51082
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.0855039	3.420156
LYSOSOMAL ACID LIPASE DEFICIENCY	0.08545991	3.4183964
INFANTILE LIVER FAILURE SYNDROME 1	0.08542071	3.4168284
TYROSINEMIA, TYPE I; TYRSN1	0.08497220999999999	3.3988883999999997
HEMOCHROMATOSIS, TYPE 1	0.08497220999999999	3.3988883999999997
CHROMOSOME 2q37 DELETION SYNDROME	0.08387789999999999	3.3551159999999998
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.0817875	3.2715
GLYCOGEN STORAGE DISEASE IXC	0.08170430999999999	3.2681723999999996
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.07951262	3.1805048000000005
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.07947551	3.1790204
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.0788114	3.152456
JOUBERT SYNDROME 6	0.0788114	3.152456
POLYCYSTIC KIDNEY DISEASE 2	0.078373	3.13492
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0775467	3.101868
PHEOCHROMOCYTOMA	0.07670450000000001	3.0681800000000004
HYPERBILIVERDINEMIA; HBLVD	0.0744828	2.9793119999999997
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.073975	2.9589999999999996
PORPHYRIA CUTANEA TARDA	0.073975	2.9589999999999996
INFANTILE LIVER FAILURE SYNDROME 2	0.0733681	2.9347240000000006
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.07284953	2.9139812
ASPARTYLGLUCOSAMINURIA; AGU	0.07277690999999999	2.9110763999999993
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0723984	2.895936
POTOCKI-LUPSKI SYNDROME	0.0721778	2.887112
MENTAL RETARDATION, X-LINKED 97; MRX97	0.07142857	2.8571428
ADAMS-OLIVER SYNDROME 6; AOS6	0.0708748	2.834992
RUIJS-AALFS SYNDROME; RJALS	0.0698125	2.7925
BASAL CELL NEVUS SYNDROME	0.06959219999999999	2.7836879999999997
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.06959219999999999	2.7836879999999997
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.06925676	2.7702704000000002
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.06912251999999999	2.7649007999999995
HOLOPROSENCEPHALY 7	0.06912251999999999	2.7649007999999995
CRI-DU-CHAT SYNDROME	0.0661541	2.6461639999999997
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.06575733	2.6302932
POLYCYSTIC LIVER DISEASE 2	0.06568471	2.6273883999999996
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.06456461000000001	2.5825844000000004
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0643224	2.572896
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.06336810000000001	2.534724
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.06299753000000001	2.5199012000000005
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.0627705	2.5108200000000003
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.0625	2.5
POLYCYSTIC KIDNEYS	0.0625	2.5
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.0625	2.5
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.0625	2.5
POLYCYSTIC KIDNEY DISEASE 3	0.0625	2.5
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0625	2.5
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0625	2.5
NEPHRONOPHTHISIS 13	0.0625	2.5
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0625	2.5
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0625	2.5
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0625	2.5
SCHEIE SYNDROME	0.0625	2.5
Pierpont syndrome	0.0625	2.5
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.0625	2.5
SMITH-MAGENIS SYNDROME; SMS	0.0625	2.5
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.062487310000000004	2.4994924000000003
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.06205883	2.4823532000000004
OMODYSPLASIA 1; OMOD1	0.061370030000000006	2.4548012
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.06092331	2.4369324000000003
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.06092331	2.4369324000000003
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.06092331	2.4369324000000003
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.0597402	2.389608
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.0588235	2.35294
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.058740310000000004	2.3496124
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.058740310000000004	2.3496124
Polyarteritis nodosa, childhood-onset	0.05861621	2.3446484
WITTEVEEN-KOLK SYNDROME	0.05849092	2.3396368
#615382 NEPHRONOPHTHISIS 16; NPHP16	0.0577386	2.3095440000000003
SENIOR-LOKEN SYNDROME 9	0.0577386	2.3095440000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.05645171	2.2580684
Lipodystrophy, congenital generalized, type 2	0.05600561	2.2402244
Lipodystrophy, congenital generalized, type 1	0.05600561	2.2402244
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.055555600000000004	2.222224
MECKEL SYNDROME, TYPE 1; MKS1	0.055555600000000004	2.222224
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.055555600000000004	2.222224
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.055555600000000004	2.222224
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.055555600000000004	2.222224
MECKEL SYNDROME, TYPE 4; MKS4	0.055555600000000004	2.222224
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.055555600000000004	2.222224
MECKEL SYNDROME, TYPE 5	0.055555600000000004	2.222224
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.0554315	2.21726
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.05501661	2.2006644
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.054624519999999996	2.1849808
PROTEUS SYNDROME	0.054383070000000006	2.1753228000000004
RENPENNING SYNDROME 1; RENS1	0.05360692	2.1442768
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.053478300000000006	2.139132
#170100 PROLIDASE DEFICIENCY	0.053419770000000005	2.1367908
SICKLE CELL ANEMIA	0.05318471	2.1273884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.05312091	2.1248364
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.05312091	2.1248364
COFFIN-SIRIS SYNDROME 1; CSS1	0.0525467	2.101868
TRICHOHEPATOENTERIC SYNDROME 1	0.05159201	2.0636804
WILLIAMS-BEUREN SYNDROME; WBS	0.050876330000000004	2.0350532
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.05080371	2.0321484
PORTAL HYPERTENSION, NONCIRRHOTIC	0.05080371	2.0321484
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.05027691	2.0110764
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.050235060000000005	2.0094024000000004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.050100820000000004	2.0040328000000005
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.05	2.0
SPHEROCYTOSIS, TYPE 1; SPH1	0.05	2.0
HEMOGLOBIN--BETA LOCUS	0.05	2.0
GLYCOGEN STORAGE DISEASE VII	0.05	2.0
#300752 PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP;;PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED DOMINANT; XLDPP;;ERYTHROHEPATIC PROTOPORPHYRIA, X-LINKED;	0.0478125	1.9124999999999999
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.047619	1.9047600000000002
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.04705261	1.8821044000000002
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.04667652	1.8670607999999997
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.046663010000000005	1.8665204000000002
NIEMANN-PICK DISEASE, TYPE C2	0.046663010000000005	1.8665204000000002
NIEMANN-PICK DISEASE, TYPE A	0.046663010000000005	1.8665204000000002
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0455537	1.822148
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0455357	1.821428
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0455357	1.821428
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.04549633	1.8198532
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0454545	1.8181800000000001
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0454545	1.8181800000000001
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0454545	1.8181800000000001
ENCHONDROMATOSIS, MULTIPLE	0.0454545	1.8181800000000001
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0454545	1.8181800000000001
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.0454545	1.8181800000000001
COWDEN SYNDROME 7; CWS7	0.0454545	1.8181800000000001
Lymphatic malformation 1	0.0454545	1.8181800000000001
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.0454545	1.8181800000000001
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0454545	1.8181800000000001
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.04530841	1.8123364
ARIMA SYNDROME	0.04530841	1.8123364
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.04521826	1.8087304000000002
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.04501661	1.8006643999999998
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.04484934	1.7939736000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.04442427	1.7769708000000002
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.04425301	1.7701204000000001
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.04388834	1.7555335999999997
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.043815719999999996	1.7526287999999997
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.04359615	1.743846
GALACTOKINASE DEFICIENCY	0.043478300000000004	1.7391320000000001
PEROXISOME BIOGENESIS DISORDER 10B	0.043478300000000004	1.7391320000000001
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.043478300000000004	1.7391320000000001
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.043478300000000004	1.7391320000000001
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.043478300000000004	1.7391320000000001
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.042617920000000004	1.7047168000000001
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.042617920000000004	1.7047168000000001
ACRORENAL-MANDIBULAR SYNDROME	0.041718830000000005	1.6687532
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.04159201	1.6636803999999998
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0409661	1.6386439999999998
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.04033882	1.6135528
EDINBURGH MALFORMATION SYNDROME	0.040303	1.6121199999999998
PROTOPORPHYRIA, ERYTHROPOIETIC	0.04	1.6
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.04	1.6
#611465 GALLBLADDER DISEASE 4; GBD4	0.04	1.6
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.04	1.6
DIGEORGE SYNDROME; DGS	0.04	1.6
MYOTONIC DYSTROPHY 1	0.04	1.6
MENTAL RETARDATION, X-LINKED 107; MRX107	0.03936059	1.5744236000000003
GAUCHER DISEASE, PERINATAL LETHAL	0.03917371	1.5669484
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.03864283	1.5457132000000002
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	1.5384600000000002
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.5384600000000002
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.5384600000000002
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.5384600000000002
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.5384600000000002
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.5384600000000002
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.5384600000000002
HYPOADRENOCORTICISM, FAMILIAL	0.0384615	1.5384600000000002
THUMB DEFORMITY	0.0384615	1.5384600000000002
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0384615	1.5384600000000002
COWDEN SYNDROME 6; CWS6	0.0384615	1.5384600000000002
ARTERIES, ANOMALIES OF	0.0384615	1.5384600000000002
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.5384600000000002
COWDEN SYNDROME 5; CWS5	0.0384615	1.5384600000000002
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.5384600000000002
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.5384600000000002
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.5384600000000002
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.5384600000000002
WATSON SYNDROME	0.0384615	1.5384600000000002
BETHLEM MYOPATHY 1	0.0384615	1.5384600000000002
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.038278389999999995	1.5311355999999998
AMYLOIDOSIS, FAMILIAL VISCERAL	0.03766751	1.5067004
TIMOTHY SYNDROME; TS	0.037013	1.4805199999999998
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.03697363	1.4789452
CHROMOSOME 10Q26 DELETION SYNDROME	0.03674184999999999	1.4696739999999997
FEINGOLD SYNDROME 1; FGLDS1	0.03674184999999999	1.4696739999999997
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.03633831	1.4535323999999998
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.036320359999999996	1.4528143999999998
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.03599721	1.4398884
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0359954	1.4398159999999998
15q26 overgrowth syndrome	0.035790569999999994	1.4316227999999998
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0353855	1.4154200000000001
FIBROCHONDROGENESIS 1; FBCG1	0.0353855	1.4154200000000001
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.0353855	1.4154200000000001
HURLER SYNDROME	0.03527691	1.4110764000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.035149509999999995	1.4059803999999998
RETICULOENDOTHELIOSIS, X-LINKED	0.035	1.4000000000000001
LETTERER-SIWE DISEASE	0.035	1.4000000000000001
HYPERLIPOPROTEINEMIA, TYPE I	0.035	1.4000000000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.03494147	1.3976588
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.03492102	1.3968407999999999
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0344828	1.379312
FUMARASE DEFICIENCY; FMRD	0.0344828	1.379312
JOHANSON-BLIZZARD SYNDROME; JBS	0.0344828	1.379312
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.0344828	1.379312
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.03443471	1.3773884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.03437649	1.3750596
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.03425301	1.3701204
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0337163	1.3486519999999997
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0337163	1.3486519999999997
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.032964	1.31856
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.03290547	1.3162188
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0328125	1.3125000000000002
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.03273807	1.3095228
MARFAN SYNDROME; MFS	0.03273807	1.3095228
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.03273807	1.3095228
SECKEL SYNDROME 9; SCKL9	0.03273807	1.3095228
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.03273807	1.3095228
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.03273807	1.3095228
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.03273807	1.3095228
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.03273807	1.3095228
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.03273807	1.3095228
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.03273807	1.3095228
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.03273807	1.3095228
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.03273807	1.3095228
BRANCHIOOTORENAL SYNDROME 1	0.03273807	1.3095228
NANCE-HORAN SYNDROME	0.03273807	1.3095228
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.03273807	1.3095228
NEMALINE MYOPATHY 1; NEM1	0.03273807	1.3095228
SOTOS SYNDROME 2	0.03273807	1.3095228
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.03273807	1.3095228
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.03273807	1.3095228
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.03273807	1.3095228
CHROMOSOME 1P36 DELETION SYNDROME	0.03260715	1.304286
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.03260715	1.304286
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.03260715	1.304286
SANDHOFF DISEASE	0.0320922	1.283688
XFE PROGEROID SYNDROME; XFEPS	0.031622	1.2648799999999998
CHOROIDAL OSTEOMA, BILATERAL	0.03125	1.25
#600630 UV-SENSITIVE SYNDROME 1; UVSS1	0.03125	1.25
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.03125	1.25
117600 CEREBRAL SARCOMA	0.03125	1.25
N SYNDROME	0.03125	1.25
#601518 PROSTATE CANCER, HEREDITARY, 1; HPC1;;PRCA1	0.03125	1.25
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.03125	1.25
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.03125	1.25
PAGET DISEASE, EXTRAMAMMARY	0.03125	1.25
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.03125	1.25
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.03125	1.25
ONCOCYTOMA	0.03125	1.25
HURIEZ SYNDROME; HRZ	0.03125	1.25
BROOKE-SPIEGLER SYNDROME; BSS	0.03125	1.25
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.03125	1.25
ICHTHYOSIS, X-LINKED	0.03125	1.25
#603956 CERVICAL CANCER	0.03125	1.25
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.03125	1.25
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.03125	1.25
ADAMANTINOMA OF LONG BONES	0.03125	1.25
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.03125	1.25
ANDROGEN INSENSITIVITY SYNDROME	0.03125	1.25
THYMOMA, FAMILIAL	0.03125	1.25
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.03125	1.25
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.03125	1.25
NASOPHARYNGEAL CARCINOMA	0.03125	1.25
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.031061619999999998	1.2424648
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.0309017	1.2360680000000002
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.2121199999999999
22q11.2 distal deletion syndrome	0.030302999999999997	1.2121199999999999
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.2121199999999999
MENKES DISEASE	0.030302999999999997	1.2121199999999999
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.2121199999999999
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.2121199999999999
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.2121199999999999
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.2121199999999999
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.2121199999999999
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.2121199999999999
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.2121199999999999
OROFACIAL CLEFT 3	0.030302999999999997	1.2121199999999999
15q13.3 microdeletion syndrome	0.030302999999999997	1.2121199999999999
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	1.2121199999999999
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.2121199999999999
DIMPLES, FACIAL	0.030302999999999997	1.2121199999999999
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.2121199999999999
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.2121199999999999
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.2121199999999999
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.2121199999999999
Growth hormone deficiency, isolated, type IA	0.030302999999999997	1.2121199999999999
NASAL BONES, ABSENCE OF	0.030302999999999997	1.2121199999999999
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	1.2121199999999999
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.030302999999999997	1.2121199999999999
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.2121199999999999
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.030302999999999997	1.2121199999999999
CLEFT CHIN	0.030302999999999997	1.2121199999999999
DWARFISM, LEVI TYPE	0.030302999999999997	1.2121199999999999
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.2121199999999999
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.030302999999999997	1.2121199999999999
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.030201230000000003	1.2080492000000003
DESBUQUOIS DYSPLASIA 2; DBQD2	0.030201230000000003	1.2080492000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.03000622	1.2002488
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.02986511	1.1946044
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.02986511	1.1946044
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.02986511	1.1946044
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.02986511	1.1946044
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.02986511	1.1946044
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.02986511	1.1946044
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.02948406	1.1793623999999998
VISCERAL STEATOSIS, CONGENITAL	0.028867900000000002	1.154716
CORNELIA DE LANGE SYNDROME 3	0.0285312	1.1412479999999998
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.0285312	1.1412479999999998
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.0285312	1.1412479999999998
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.02818471	1.1273884
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.02818471	1.1273884
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.02818471	1.1273884
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.028058899999999998	1.122356
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.028000419999999998	1.1200168
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.027961049999999998	1.118442
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.027876909999999998	1.1150764
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.0269439	1.077756
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0269439	1.077756
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.0269439	1.077756
CHROMOSOME 17q12 DELETION SYNDROME	0.026942829999999997	1.0777131999999998
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.026861999999999997	1.0744799999999999
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.0266804	1.067216
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0266804	1.067216
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.02654009	1.0616036
JOUBERT SYNDROME 1	0.02651313	1.0605251999999998
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.02651313	1.0605251999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.02644051	1.0576204
KLEEFSTRA SYNDROME	0.02637292	1.0549168000000002
HEMOCHROMATOSIS, TYPE 2B	0.02614871	1.0459484
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.02614871	1.0459484
HYPERTELORISM AND TETRALOGY OF FALLOT	0.025984629999999998	1.0393852
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.025984629999999998	1.0393852
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.025842910000000004	1.0337164
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.025752849999999997	1.0301139999999998
KBG SYNDROME	0.0252747	1.010988
NEUTROPHILIA, HEREDITARY	0.025	1.0
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.025	1.0
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.025	1.0
BENT BONE DYSPLASIA SYNDROME; BBDS	0.025	1.0
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.025	1.0
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.025	1.0
MCLEOD SYNDROME; MCLDS	0.025	1.0
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.025	1.0
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.025	1.0
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.025	1.0
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.025	1.0
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.025	1.0
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.025	1.0
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.025	1.0
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.025	1.0
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.025	1.0
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0248441	0.9937640000000001
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.02480157	0.9920627999999999
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.02417371	0.9669484
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.02416555	0.966622
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.02416555	0.966622
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.02409293	0.9637171999999999
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0238095	0.9523800000000001
BLOOM SYNDROME	0.0238095	0.9523800000000001
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0238095	0.9523800000000001
CRANIOACROFACIAL SYNDROME	0.0238095	0.9523800000000001
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0238095	0.9523800000000001
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.0238095	0.9523800000000001
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.0238095	0.9523800000000001
Bangstad syndrome	0.0238095	0.9523800000000001
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0238095	0.9523800000000001
ODONTOCHONDRODYSPLASIA; ODCD	0.0238095	0.9523800000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.02357827	0.9431307999999999
NEPHRONOPHTHISIS 11; NPHP11	0.0232558	0.930232
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.0232558	0.930232
PORPHYRIA CUTANEA TARDA, TYPE I	0.0232558	0.930232
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.0232558	0.930232
#604387 NEPHRONOPHTHISIS 3; NPHP3;;NPH3	0.0232558	0.930232
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.023214270000000002	0.9285708
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.023174900000000002	0.926996
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.022965199999999998	0.9186079999999999
HEMOCHROMATOSIS, TYPE 3; HFE3	0.022964	0.9185599999999998
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.02293511	0.9174044000000001
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0227273	0.9090919999999999
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.0227273	0.9090919999999999
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0227273	0.9090919999999999
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0227273	0.9090919999999999
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0227273	0.9090919999999999
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0227273	0.9090919999999999
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0227273	0.9090919999999999
EVEN-PLUS SYNDROME	0.0227273	0.9090919999999999
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.0227273	0.9090919999999999
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0227273	0.9090919999999999
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0227273	0.9090919999999999
#256520 NEU-LAXOVA SYNDROME; NLS	0.0227273	0.9090919999999999
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0227273	0.9090919999999999
#611363 ATRIAL SEPTAL DEFECT 4; ASD4	0.0227273	0.9090919999999999
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0227273	0.9090919999999999
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.0227273	0.9090919999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.02262976	0.9051904
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.02262976	0.9051904
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.02253805	0.901522
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.02253805	0.901522
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.02253805	0.901522
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.02253805	0.901522
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.02253805	0.901522
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.02253805	0.901522
EMANUEL SYNDROME	0.022495519999999998	0.8998207999999999
CHANARIN-DORFMAN SYNDROME	0.02205261	0.8821044
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.02205261	0.8821044
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.02205261	0.8821044
#615238 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH CIDEC MUTATIONS	0.02205261	0.8821044
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.02166721	0.8666883999999999
SIMOSA CRANIOFACIAL SYNDROME	0.02158677	0.8634708000000001
CHOPS SYNDROME; CHOPS	0.0213779	0.8551159999999999
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.020997210000000002	0.8398884000000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.020908219999999998	0.8363288
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.02086885	0.834754
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.020006219999999998	0.8002487999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.020006219999999998	0.8002487999999999
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.020006219999999998	0.8002487999999999
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.01999801	0.7999204
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.019917570000000002	0.7967028
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.019917570000000002	0.7967028
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.01928072	0.7712288
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.01928072	0.7712288
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.019130329999999997	0.7652131999999999
DUANE-RADIAL RAY SYNDROME; DRRS	0.019130329999999997	0.7652131999999999
OCULOECTODERMAL SYNDROME; OES	0.019130329999999997	0.7652131999999999
LAMB-SHAFFER SYNDROME	0.019130329999999997	0.7652131999999999
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.0188679	0.7547159999999999
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.0188679	0.7547159999999999
%613282 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1, INCLUDED	0.0188679	0.7547159999999999
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.0188679	0.7547159999999999
300270 ADRENOMYODYSTROPHY	0.0188679	0.7547159999999999
PATENT DUCTUS VENOSUS	0.0188679	0.7547159999999999
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.0188679	0.7547159999999999
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.0188679	0.7547159999999999
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.0188679	0.7547159999999999
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.0188679	0.7547159999999999
%613387 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	0.0188679	0.7547159999999999
KOOLEN-DE VRIES SYNDROME; KDVS	0.01880842	0.7523368
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.01880842	0.7523368
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.01880842	0.7523368
HEMOCHROMATOSIS, TYPE 2A	0.01833621	0.7334484
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.01833621	0.7334484
GALACTOSEMIA	0.01833621	0.7334484
CITRULLINEMIA, CLASSIC	0.01833621	0.7334484
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.017812500000000002	0.7125000000000001
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.017812500000000002	0.7125000000000001
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.01761152	0.7044607999999999
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.01761152	0.7044607999999999
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.01761152	0.7044607999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.01754303	0.7017212
THAUVIN-ROBINET-FAIVRE SYNDROME	0.01754303	0.7017212
COHEN-GIBSON SYNDROME; COGIS	0.01754303	0.7017212
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.01754303	0.7017212
WEAVER SYNDROME	0.01754303	0.7017212
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.01754303	0.7017212
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.01754303	0.7017212
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.01747041	0.6988164
COFFIN-SIRIS SYNDROME 6; CSS6	0.01710629	0.6842516
SIFRIM-HITZ-WEISS SYNDROME	0.01697205	0.6788819999999999
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.01697205	0.6788819999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.01697205	0.6788819999999999
PALLISTER-KILLIAN SYNDROME	0.01697205	0.6788819999999999
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01689943	0.6759772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.016821509999999998	0.6728603999999999
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.016821509999999998	0.6728603999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.016821509999999998	0.6728603999999999
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.016821509999999998	0.6728603999999999
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.016821509999999998	0.6728603999999999
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.016821509999999998	0.6728603999999999
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.016821509999999998	0.6728603999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.01663661	0.6654644
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.01663661	0.6654644
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.016101209999999998	0.6440483999999999
RAYNAUD-CLAES SYNDROME; MRXSRC	0.01602077	0.6408307999999999
SHUKLA-VERNON SYNDROME; SHUVER	0.01602077	0.6408307999999999
PETTIGREW SYNDROME	0.01602077	0.6408307999999999
FRAGILE X MENTAL RETARDATION SYNDROME	0.01602077	0.6408307999999999
WIEDEMANN-STEINER SYNDROME; WDSTS	0.01591553	0.6366212
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.01591553	0.6366212
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.01591553	0.6366212
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.01591553	0.6366212
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.01591553	0.6366212
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.01591553	0.6366212
METAPHYSEAL ACROSCYPHODYSPLASIA	0.01591553	0.6366212
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.01591553	0.6366212
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.01591553	0.6366212
SECKEL SYNDROME 1; SCKL1	0.015872999999999998	0.6349199999999999
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.015872999999999998	0.6349199999999999
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.015872999999999998	0.6349199999999999
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.015872999999999998	0.6349199999999999
CRANIOFRONTONASAL SYNDROME; CFNS	0.015872999999999998	0.6349199999999999
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.015872999999999998	0.6349199999999999
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.015872999999999998	0.6349199999999999
WILDERVANCK SYNDROME	0.015872999999999998	0.6349199999999999
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.015872999999999998	0.6349199999999999
DEAFNESS-CRANIOFACIAL SYNDROME	0.015872999999999998	0.6349199999999999
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.015872999999999998	0.6349199999999999
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.015872999999999998	0.6349199999999999
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.015872999999999998	0.6349199999999999
OCULOCEREBROCUTANEOUS SYNDROME	0.015872999999999998	0.6349199999999999
ZTTK SYNDROME; ZTTKS	0.015872999999999998	0.6349199999999999
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.015872999999999998	0.6349199999999999
ELSAHY-WATERS SYNDROME; ESWS	0.015872999999999998	0.6349199999999999
HEMIFACIAL HYPERPLASIA	0.015872999999999998	0.6349199999999999
SCLEROSTEOSIS 2; SOST2	0.015872999999999998	0.6349199999999999
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.015872999999999998	0.6349199999999999
TORTICOLLIS	0.015872999999999998	0.6349199999999999
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.015872999999999998	0.6349199999999999
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.015872999999999998	0.6349199999999999
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.015872999999999998	0.6349199999999999
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.015872999999999998	0.6349199999999999
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.015872999999999998	0.6349199999999999
GABRIELE-DE VRIES SYNDROME; GADEVS	0.015872999999999998	0.6349199999999999
CURRY-JONES SYNDROME	0.015872999999999998	0.6349199999999999
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.015872999999999998	0.6349199999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.015872999999999998	0.6349199999999999
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.015872999999999998	0.6349199999999999
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.015872999999999998	0.6349199999999999
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.015872999999999998	0.6349199999999999
FOCAL DERMAL HYPOPLASIA; FDH	0.015872999999999998	0.6349199999999999
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.015872999999999998	0.6349199999999999
PEROXISOME BIOGENESIS DISORDER 3B	0.01584291	0.6337164000000001
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.01584291	0.6337164000000001
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.01576577	0.6306307999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.01576577	0.6306307999999999
HAREL-YOON SYNDROME; HAYOS	0.01555109	0.6220436
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.01555109	0.6220436
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.01555109	0.6220436
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.01555109	0.6220436
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.015451050000000001	0.6180420000000001
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.015151499999999998	0.6060599999999999
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.015151499999999998	0.6060599999999999
CRANIOECTODERMAL DYSPLASIA 3	0.015151499999999998	0.6060599999999999
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.015151499999999998	0.6060599999999999
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.015151499999999998	0.6060599999999999
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.015151499999999998	0.6060599999999999
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.015151499999999998	0.6060599999999999
SEA-BLUE HISTIOCYTE DISEASE	0.015151499999999998	0.6060599999999999
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.015151499999999998	0.6060599999999999
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0149047	0.596188
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0142857	0.571428
DESBUQUOIS DYSPLASIA 1	0.0142857	0.571428
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.0142857	0.571428
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.0142857	0.571428
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.0142857	0.571428
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.0142857	0.571428
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.0142857	0.571428
Aarskog-Scott syndrome	0.0142857	0.571428
DYSOSTEOSCLEROSIS	0.0142857	0.571428
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0142857	0.571428
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.0142857	0.571428
#156550 KNIEST DYSPLASIA	0.0142857	0.571428
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.0142857	0.571428
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.0142857	0.571428
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.0142857	0.571428
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.0142857	0.571428
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.0142857	0.571428
SONODA SYNDROME	0.0142857	0.571428
Ullrich congenital muscular dystrophy 1	0.0142857	0.571428
BRACHYDACTYLY, TYPE E	0.0142857	0.571428
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.0142857	0.571428
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.0142857	0.571428
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0142857	0.571428
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.0142857	0.571428
ACROMICRIC DYSPLASIA	0.0142857	0.571428
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0142857	0.571428
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.0142857	0.571428
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0142857	0.571428
BARTH SYNDROME; BTHS	0.0142857	0.571428
CHROMOSOME 18P DELETION SYNDROME	0.0142857	0.571428
2q37 monosomy	0.0142857	0.571428
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0142857	0.571428
CHERUBISM	0.0142857	0.571428
Mulchandani-Bhoj-Conlin syndrome	0.014246330000000001	0.5698532000000001
LEGIUS SYNDROME	0.014246330000000001	0.5698532000000001
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.014246330000000001	0.5698532000000001
AL KAISSI SYNDROME; ALKAS	0.014246330000000001	0.5698532000000001
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.014246330000000001	0.5698532000000001
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.014246330000000001	0.5698532000000001
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.014246330000000001	0.5698532000000001
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.01417371	0.5669484
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.01371472	0.5485888
PITT-HOPKINS SYNDROME	0.01371472	0.5485888
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.01353424	0.5413696
INFANTILE SIALIC ACID STORAGE DISEASE	0.01353424	0.5413696
OCULOSKELETODENTAL SYNDROME; OCSKD	0.01353424	0.5413696
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01353424	0.5413696
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.01353424	0.5413696
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.01337928	0.5351712
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01337928	0.5351712
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.01337928	0.5351712
MCDONOUGH SYNDROME	0.01337928	0.5351712
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.01337928	0.5351712
VERVERI-BRADY SYNDROME; VERBRAS	0.01337928	0.5351712
HOLOPROSENCEPHALY 5; HPE5	0.01337928	0.5351712
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.01337928	0.5351712
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.01337928	0.5351712
OROFACIODIGITAL SYNDROME XIV; OFD14	0.01337928	0.5351712
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.01318471	0.5273884000000001
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.01318471	0.5273884000000001
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.01318471	0.5273884000000001
GALACTOSE EPIMERASE DEFICIENCY	0.01318471	0.5273884000000001
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.01318471	0.5273884000000001
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.01318471	0.5273884000000001
#613977 CYANOSIS, TRANSIENT NEONATAL; TNCY	0.01318471	0.5273884000000001
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.01318471	0.5273884000000001
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.01318471	0.5273884000000001
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.01318471	0.5273884000000001
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.01318471	0.5273884000000001
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.01318471	0.5273884000000001
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.01318471	0.5273884000000001
C SYNDROME	0.01306456	0.5225824
ROBINOW-SORAUF SYNDROME	0.012658200000000001	0.5063280000000001
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.012658200000000001	0.5063280000000001
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.012658200000000001	0.5063280000000001
#600972 ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE	0.012658200000000001	0.5063280000000001
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.012658200000000001	0.5063280000000001
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.012658200000000001	0.5063280000000001
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.012658200000000001	0.5063280000000001
LARSEN-LIKE SYNDROME	0.012658200000000001	0.5063280000000001
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.012658200000000001	0.5063280000000001
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.012658200000000001	0.5063280000000001
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.012658200000000001	0.5063280000000001
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.012658200000000001	0.5063280000000001
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.012658200000000001	0.5063280000000001
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.012658200000000001	0.5063280000000001
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.012658200000000001	0.5063280000000001
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.012658200000000001	0.5063280000000001
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.012658200000000001	0.5063280000000001
#150250 LARSEN SYNDROME; LRS	0.012658200000000001	0.5063280000000001
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.012658200000000001	0.5063280000000001
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.012658200000000001	0.5063280000000001
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.012658200000000001	0.5063280000000001
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.012658200000000001	0.5063280000000001
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.012658200000000001	0.5063280000000001
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.012658200000000001	0.5063280000000001
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.012658200000000001	0.5063280000000001
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.012658200000000001	0.5063280000000001
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.012658200000000001	0.5063280000000001
KYPHOMELIC DYSPLASIA	0.012658200000000001	0.5063280000000001
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.012658200000000001	0.5063280000000001
OROFACIODIGITAL SYNDROME XV; OFD15	0.012658200000000001	0.5063280000000001
KNIEST-LIKE DYSPLASIA, LETHAL	0.012658200000000001	0.5063280000000001
AL-RAQAD SYNDROME; ARS	0.012658200000000001	0.5063280000000001
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.012658200000000001	0.5063280000000001
PYRUVATE CARBOXYLASE DEFICIENCY	0.01219372	0.48774880000000004
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.01219372	0.48774880000000004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.01219372	0.48774880000000004
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.01219372	0.48774880000000004
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.01219372	0.48774880000000004
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01219372	0.48774880000000004
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.01219372	0.48774880000000004
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.0121859	0.4874359999999999
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.0121859	0.4874359999999999
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0121859	0.4874359999999999
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0121859	0.4874359999999999
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.01099721	0.43988840000000007
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.01099721	0.43988840000000007
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.01099721	0.43988840000000007
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.01099721	0.43988840000000007
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.01099721	0.43988840000000007
RETINITIS PIGMENTOSA 59; RP59	0.01099721	0.43988840000000007
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.01099721	0.43988840000000007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.01099721	0.43988840000000007
PSEUDO-TORCH SYNDROME 2	0.01099721	0.43988840000000007
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.01099721	0.43988840000000007
GLYCOGEN STORAGE DISEASE IXA	0.01099721	0.43988840000000007
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.010989	0.43956000000000006
MEIER-GORLIN SYNDROME 3; MGORS3	0.010989	0.43956000000000006
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.010989	0.43956000000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.010989	0.43956000000000006
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.010989	0.43956000000000006
FONTAINE PROGEROID SYNDROME; FPS	0.010989	0.43956000000000006
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.010989	0.43956000000000006
COLE-CARPENTER SYNDROME 2; CLCRP2	0.010989	0.43956000000000006
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.010989	0.43956000000000006
OSTEOGENESIS IMPERFECTA, TYPE X	0.010989	0.43956000000000006
RUSSELL-SILVER SYNDROME, X-LINKED	0.010989	0.43956000000000006
THREE M SYNDROME 2; 3M2	0.010989	0.43956000000000006
OSTEOGENESIS IMPERFECTA, TYPE V	0.010989	0.43956000000000006
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.010989	0.43956000000000006
POPOV-CHANG SYNDROME; POPCHAS	0.010989	0.43956000000000006
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.010989	0.43956000000000006
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.010989	0.43956000000000006
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.010989	0.43956000000000006
WOODHOUSE-SAKATI SYNDROME	0.010989	0.43956000000000006
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.010989	0.43956000000000006
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.010989	0.43956000000000006
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.010989	0.43956000000000006
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.010989	0.43956000000000006
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.010989	0.43956000000000006
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.010989	0.43956000000000006
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.010989	0.43956000000000006
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.010989	0.43956000000000006
MEIER-GORLIN SYNDROME 5; MGORS5	0.010989	0.43956000000000006
FLOATING-HARBOR SYNDROME	0.010989	0.43956000000000006
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.010989	0.43956000000000006
SHORT SYNDROME	0.010989	0.43956000000000006
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.010989	0.43956000000000006
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.010989	0.43956000000000006
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.010989	0.43956000000000006
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.010989	0.43956000000000006
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.010989	0.43956000000000006
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.010989	0.43956000000000006
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.010989	0.43956000000000006
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.010989	0.43956000000000006
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.010989	0.43956000000000006
CREE MENTAL RETARDATION SYNDROME	0.010989	0.43956000000000006
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.01034953	0.41398119999999994
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.01034953	0.41398119999999994
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.01034953	0.41398119999999994
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.01034953	0.41398119999999994
OGDEN SYNDROME; OGDNS	0.01034953	0.41398119999999994
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.01034953	0.41398119999999994
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.01034953	0.41398119999999994
COSTELLO SYNDROME; CSTLO	0.01034953	0.41398119999999994
MUCOPOLYSACCHARIDOSIS, TYPE II	0.01027691	0.4110764
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.01027691	0.4110764
MORQUIO SYNDROME A	0.01027691	0.4110764
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.01027691	0.4110764
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.01027691	0.4110764
Glycosylphosphatidylinositol biosynthesis defect 18	0.01027691	0.4110764
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.01027691	0.4110764
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01027691	0.4110764
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.01027691	0.4110764
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.01027691	0.4110764
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.01027691	0.4110764
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.01027691	0.4110764
ZIMMERMANN-LABAND SYNDROME 1	0.01027691	0.4110764
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.01027691	0.4110764
NEURAMINIDASE DEFICIENCY	0.01027691	0.4110764
SHPRINTZEN OMPHALOCELE SYNDROME	0.01001409	0.4005636
LICHTENSTEIN SYNDROME	0.01001409	0.4005636
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.01001409	0.4005636
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.01001409	0.4005636
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.01001409	0.4005636
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.01001409	0.4005636
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.01001409	0.4005636
NOONAN SYNDROME 5; NS5	0.01001409	0.4005636
MEGAEPIPHYSEAL DWARFISM	0.01001409	0.4005636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.01001409	0.4005636
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.01001409	0.4005636
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01001409	0.4005636
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01001409	0.4005636
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.01001409	0.4005636
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.01001409	0.4005636
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.01001409	0.4005636
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.01001409	0.4005636
MENTAL RETARDATION, X-LINKED 91; MRX91	0.01001409	0.4005636
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.01001409	0.4005636
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.01001409	0.4005636
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.01001409	0.4005636
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.01	0.4
GILBERT SYNDROME	0.01	0.4
RH-NULL, REGULATOR TYPE; RHNR	0.01	0.4
CRIGLER-NAJJAR SYNDROME, TYPE II	0.01	0.4
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.01	0.4
ACETAMINOPHEN METABOLISM	0.01	0.4
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.01	0.4
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.01	0.4
HYPERBILIRUBINEMIA, ROTOR TYPE	0.01	0.4
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.01	0.4
HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	0.01	0.4
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.01	0.4
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.01	0.4
224250 DYSMYELINATION WITH JAUNDICE	0.01	0.4
ELLIPTOCYTOSIS 1; EL1	0.01	0.4
SPECTRIN, BETA, ERYTHROCYTIC	0.01	0.4
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.01	0.4
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.01	0.4
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.01	0.4
SPHEROCYTOSIS, TYPE 2	0.01	0.4
ACTH DEFICIENCY, ISOLATED; IAD	0.01	0.4
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.01	0.4
JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	0.01	0.4
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.009941469999999999	0.3976588
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.009941469999999999	0.3976588
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.009879849999999999	0.39519399999999993
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.009879849999999999	0.39519399999999993
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.009879849999999999	0.39519399999999993
#614976 CARPENTER SYNDROME 2; CRPT2	0.009879849999999999	0.39519399999999993
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.009879849999999999	0.39519399999999993
CHROMOSOME 9P DELETION SYNDROME	0.009879849999999999	0.39519399999999993
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.009879849999999999	0.39519399999999993
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.009879849999999999	0.39519399999999993
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.009879849999999999	0.39519399999999993
SCHOLTE SYNDROME; SHLTS	0.009879849999999999	0.39519399999999993
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.009879849999999999	0.39519399999999993
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.009879849999999999	0.39519399999999993
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.009879849999999999	0.39519399999999993
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.009879849999999999	0.39519399999999993
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.009879849999999999	0.39519399999999993
CHROMOSOME 16Q22 DELETION SYNDROME	0.009879849999999999	0.39519399999999993
OROFACIAL CLEFT 15	0.009879849999999999	0.39519399999999993
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.009879849999999999	0.39519399999999993
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00980723	0.3922892
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00900901	0.36036039999999997
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00900901	0.36036039999999997
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00900901	0.36036039999999997
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00900901	0.36036039999999997
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.00900901	0.36036039999999997
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00900901	0.36036039999999997
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00900901	0.36036039999999997
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00900901	0.36036039999999997
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00900901	0.36036039999999997
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00900901	0.36036039999999997
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.00900901	0.36036039999999997
SENGERS SYNDROME	0.00900901	0.36036039999999997
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.00900901	0.36036039999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00900901	0.36036039999999997
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.00900901	0.36036039999999997
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.00900901	0.36036039999999997
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00900901	0.36036039999999997
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00900901	0.36036039999999997
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00900901	0.36036039999999997
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.00900901	0.36036039999999997
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00900901	0.36036039999999997
PERRAULT SYNDROME 5; PRLTS5	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00900901	0.36036039999999997
GLYCOGEN STORAGE DISEASE 0, LIVER	0.00900901	0.36036039999999997
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00900901	0.36036039999999997
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.00900901	0.36036039999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00900901	0.36036039999999997
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00900901	0.36036039999999997
LEBER OPTIC ATROPHY AND DYSTONIA	0.00900901	0.36036039999999997
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00900901	0.36036039999999997
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00900901	0.36036039999999997
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00900901	0.36036039999999997
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00900901	0.36036039999999997
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00900901	0.36036039999999997
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00900901	0.36036039999999997
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.00900901	0.36036039999999997
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.00900901	0.36036039999999997
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00900901	0.36036039999999997
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00900901	0.36036039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.00900901	0.36036039999999997
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00900901	0.36036039999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00900901	0.36036039999999997
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00900901	0.36036039999999997
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00900901	0.36036039999999997
OTODENTAL DYSPLASIA	0.00892857	0.35714280000000004
CHROMOSOME 1p35 DELETION SYNDROME	0.00892857	0.35714280000000004
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00892857	0.35714280000000004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00892857	0.35714280000000004
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00892857	0.35714280000000004
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00892857	0.35714280000000004
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.00892857	0.35714280000000004
TURNPENNY-FRY SYNDROME; TPFS	0.00892857	0.35714280000000004
OTOFACIOCERVICAL SYNDROME	0.00892857	0.35714280000000004
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00892857	0.35714280000000004
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00892857	0.35714280000000004
17q21.31 recurrent microdeletion syndrome	0.00892857	0.35714280000000004
LUSCAN-LUMISH SYNDROME; LLS	0.00892857	0.35714280000000004
SHASHI-PENA SYNDROME; SHAPNS	0.00892857	0.35714280000000004
MARFANOID HABITUS WITH SITUS INVERSUS	0.00892857	0.35714280000000004
MENTAL RETARDATION, X-LINKED 72	0.00892857	0.35714280000000004
MEHMO SYNDROME; MEHMO	0.00892857	0.35714280000000004
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00892857	0.35714280000000004
GLASS SYNDROME	0.00892857	0.35714280000000004
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00892857	0.35714280000000004
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.00892857	0.35714280000000004
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.00892857	0.35714280000000004
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00892857	0.35714280000000004
MENTAL RETARDATION, X-LINKED 101; MRX101	0.00892857	0.35714280000000004
ARTERIAL TORTUOSITY SYNDROME	0.00892857	0.35714280000000004
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.00892857	0.35714280000000004
KEUTEL SYNDROME; KTLS	0.00892857	0.35714280000000004
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00892857	0.35714280000000004
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00892857	0.35714280000000004
AU-KLINE SYNDROME; AUKS	0.00892857	0.35714280000000004
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.00892857	0.35714280000000004
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00892857	0.35714280000000004
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.00892857	0.35714280000000004
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00892857	0.35714280000000004
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00892857	0.35714280000000004
RAPADILINO SYNDROME	0.00892857	0.35714280000000004
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00892857	0.35714280000000004
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00892857	0.35714280000000004
LOEYS-DIETZ SYNDROME 3; LDS3	0.00892857	0.35714280000000004
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.00892857	0.35714280000000004
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.00892857	0.35714280000000004
MENTAL RETARDATION, X-LINKED 93	0.00892857	0.35714280000000004
SOTOS SYNDROME 3	0.00892857	0.35714280000000004
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00892857	0.35714280000000004
3q29 microdeletion syndrome	0.00892857	0.35714280000000004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00892857	0.35714280000000004
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.00892857	0.35714280000000004
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00892857	0.35714280000000004
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00892857	0.35714280000000004
TEMTAMY SYNDROME; TEMTYS	0.00892857	0.35714280000000004
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.0078125	0.3125
PREECLAMPSIA/ECLAMPSIA 1	0.0078125	0.3125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.0078125	0.3125
BARDET-BIEDL SYNDROME 21; BBS21	0.0078125	0.3125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.0078125	0.3125
RETINITIS PIGMENTOSA 71; RP71	0.0078125	0.3125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0078125	0.3125
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.0078125	0.3125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.0078125	0.3125
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0078125	0.3125
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.0070922	0.283688
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.0070922	0.283688
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0070922	0.283688
SCHAAF-YANG SYNDROME; SHFYNG	0.0070922	0.283688
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.0070922	0.283688
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.0070922	0.283688
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0070922	0.283688
MACS SYNDROME	0.0070922	0.283688
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0070922	0.283688
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0070922	0.283688
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0070922	0.283688
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0070922	0.283688
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0070922	0.283688
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0070922	0.283688
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.0070922	0.283688
DESANTO-SHINAWI SYNDROME	0.0070922	0.283688
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0070922	0.283688
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.0070922	0.283688
FRANK-TER HAAR SYNDROME; FTHS	0.0070922	0.283688
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.0070922	0.283688
GENITOPATELLAR SYNDROME; GTPTS	0.0070922	0.283688
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0070922	0.283688
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0070922	0.283688
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.0070922	0.283688
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0070922	0.283688
COFFIN-SIRIS SYNDROME 5	0.0070922	0.283688
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0070922	0.283688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0070922	0.283688
COFFIN-SIRIS SYNDROME 2; CSS2	0.0070922	0.283688
COFFIN-LOWRY SYNDROME; CLS	0.0070922	0.283688
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.0070922	0.283688
MENTAL RETARDATION, X-LINKED 103	0.0070922	0.283688
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.0070922	0.283688
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0070922	0.283688
268650 RUDIGER SYNDROME	0.0070922	0.283688
COFFIN-SIRIS SYNDROME 4; CSS4	0.0070922	0.283688
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.0070922	0.283688
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.0070922	0.283688
HYALINE FIBROMATOSIS SYNDROME; HFS	0.0070922	0.283688
#277950 WINCHESTER SYNDROME; WNCHRS	0.0070922	0.283688
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0070922	0.283688
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0070922	0.283688
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.0070922	0.283688
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0070922	0.283688
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0070922	0.283688
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.0070922	0.283688
COFFIN-SIRIS SYNDROME 7; CSS7	0.0070922	0.283688
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.0070922	0.283688
NF1-microdeletion syndrome	0.0070922	0.283688
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.0070922	0.283688
CLARK-BARAITSER SYNDROME	0.0070922	0.283688
COFFIN-SIRIS SYNDROME 3; CSS3	0.0070922	0.283688
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0070922	0.283688
ATKIN-FLAITZ SYNDROME	0.0070922	0.283688
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0070922	0.283688
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.0070922	0.283688
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0070922	0.283688
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0070922	0.283688
FOUNTAIN SYNDROME	0.0070922	0.283688
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0070922	0.283688
Helsmoortel-van der Aa syndrome	0.0070922	0.283688
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.0070922	0.283688
#151210 PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT;;LETHAL SHORT-LIMBED PLATYSPONDYLIC DWARFISM, TORRANCE TYPE;;THANATOPHORIC DYSPLASIA, TORRANCE VARIANTPLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, LUTON TYPE, INCLUDED; PLSDL,INCLUDED;;THANATOPHORIC DYSPLASIA, LUTON VARIANT, INCLUDED	0.0070922	0.283688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0070922	0.283688
MUCOLIPIDOSIS III GAMMA	0.0070922	0.283688
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.0070922	0.283688
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0070922	0.283688
FRONTOMETAPHYSEAL DYSPLASIA	0.0070922	0.283688
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.0070922	0.283688
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.0070922	0.283688
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.0070922	0.283688
MUCOLIPIDOSIS III ALPHA/BETA	0.0070922	0.283688
ENDOCARDIAL FIBROELASTOSIS	0.00675676	0.27027039999999997
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00675676	0.27027039999999997
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00675676	0.27027039999999997
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00675676	0.27027039999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00675676	0.27027039999999997
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.00675676	0.27027039999999997
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00675676	0.27027039999999997
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00675676	0.27027039999999997
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00675676	0.27027039999999997
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00675676	0.27027039999999997
HAIRY ELBOWS	0.00675676	0.27027039999999997
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00675676	0.27027039999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00675676	0.27027039999999997
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00675676	0.27027039999999997
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00675676	0.27027039999999997
GLYCEROL KINASE DEFICIENCY; GKD	0.00675676	0.27027039999999997
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00675676	0.27027039999999997
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00675676	0.27027039999999997
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.00675676	0.27027039999999997
ZECHI-CEIDE SYNDROME	0.00675676	0.27027039999999997
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00675676	0.27027039999999997
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00675676	0.27027039999999997
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.00675676	0.27027039999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00675676	0.27027039999999997
CHROMOSOME 16p13.2 DELETION SYNDROME	0.00675676	0.27027039999999997
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00675676	0.27027039999999997
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00675676	0.27027039999999997
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00675676	0.27027039999999997
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00675676	0.27027039999999997
JOUBERT SYNDROME 35; JBTS35	0.00675676	0.27027039999999997
NEPHROSIALIDOSIS	0.00675676	0.27027039999999997
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00675676	0.27027039999999997
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00675676	0.27027039999999997
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.00675676	0.27027039999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.00675676	0.27027039999999997
EPILEPSY-TELANGIECTASIA	0.00675676	0.27027039999999997
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00675676	0.27027039999999997
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00675676	0.27027039999999997
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00675676	0.27027039999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00675676	0.27027039999999997
#615665 JOUBERT SYNDROME 22; JBTS22	0.00675676	0.27027039999999997
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00675676	0.27027039999999997
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00675676	0.27027039999999997
601095 HARROD SYNDROME	0.00675676	0.27027039999999997
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.00675676	0.27027039999999997
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00675676	0.27027039999999997
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00675676	0.27027039999999997
IRIDOGONIODYSGENESIS, TYPE 2	0.00675676	0.27027039999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00675676	0.27027039999999997
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00675676	0.27027039999999997
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00675676	0.27027039999999997
RODRIGUES BLINDNESS	0.00675676	0.27027039999999997
KLEEFSTRA SYNDROME 2; KLEFS2	0.00675676	0.27027039999999997
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00675676	0.27027039999999997
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.00675676	0.27027039999999997
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00675676	0.27027039999999997
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00675676	0.27027039999999997
MENTAL RETARDATION, X-LINKED 100	0.00675676	0.27027039999999997
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00675676	0.27027039999999997
MENTAL RETARDATION, X-LINKED 102	0.00675676	0.27027039999999997
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00675676	0.27027039999999997
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00675676	0.27027039999999997
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00675676	0.27027039999999997
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.00675676	0.27027039999999997
DIAMOND-BLACKFAN ANEMIA 4	0.00675676	0.27027039999999997
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00675676	0.27027039999999997
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00675676	0.27027039999999997
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.00675676	0.27027039999999997
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00675676	0.27027039999999997
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.00675676	0.27027039999999997
ROIFMAN-CHITAYAT SYNDROME	0.00675676	0.27027039999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00675676	0.27027039999999997
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00675676	0.27027039999999997
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00675676	0.27027039999999997
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00675676	0.27027039999999997
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00675676	0.27027039999999997
UROFACIAL SYNDROME	0.00675676	0.27027039999999997
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00675676	0.27027039999999997
KENNERKNECHT SYNDROME	0.00675676	0.27027039999999997
MENTAL RETARDATION, X-LINKED 14	0.00675676	0.27027039999999997
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00675676	0.27027039999999997
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00675676	0.27027039999999997
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00675676	0.27027039999999997
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.00675676	0.27027039999999997
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00675676	0.27027039999999997
JABERI-ELAHI SYNDROME; JABELS	0.00675676	0.27027039999999997
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00675676	0.27027039999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00675676	0.27027039999999997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00675676	0.27027039999999997
IMMUNODEFICIENCY 55; IMD55	0.00675676	0.27027039999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00675676	0.27027039999999997
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00675676	0.27027039999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00675676	0.27027039999999997
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00662252	0.2649008
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.00662252	0.2649008
HYPERTELORISM, TEEBI TYPE; TBHS	0.00662252	0.2649008
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00662252	0.2649008
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.00662252	0.2649008
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00662252	0.2649008
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00662252	0.2649008
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.00662252	0.2649008
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00662252	0.2649008
WIEACKER-WOLFF SYNDROME	0.00662252	0.2649008
MENTAL RETARDATION, X-LINKED 90	0.00662252	0.2649008
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00662252	0.2649008
HUNTER-MACDONALD SYNDROME	0.00662252	0.2649008
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00662252	0.2649008
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00662252	0.2649008
260150 PALANT CLEFT PALATE SYNDROME	0.00662252	0.2649008
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00662252	0.2649008
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.00662252	0.2649008
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00662252	0.2649008
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00662252	0.2649008
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00662252	0.2649008
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.00662252	0.2649008
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00662252	0.2649008
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00662252	0.2649008
IMMUNODEFICIENCY 49; IMD49	0.00662252	0.2649008
PSEUDOTRISOMY 13 SYNDROME	0.00662252	0.2649008
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00662252	0.2649008
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00662252	0.2649008
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00662252	0.2649008
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.00662252	0.2649008
NIJMEGEN BREAKAGE SYNDROME	0.00662252	0.2649008
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00662252	0.2649008
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00662252	0.2649008
PRADER-WILLI SYNDROME; PWS	0.00662252	0.2649008
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00662252	0.2649008
YUNIS-VARON SYNDROME	0.00662252	0.2649008
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00662252	0.2649008
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00662252	0.2649008
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00662252	0.2649008
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00662252	0.2649008
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00662252	0.2649008
FRONTONASAL DYSPLASIA 2; FND2	0.00662252	0.2649008
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00662252	0.2649008
XIA-GIBBS SYNDROME	0.00662252	0.2649008
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00644204	0.2576816
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00644204	0.2576816
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00325733	0.13029320000000003
MARTSOLF SYNDROME	0.00325733	0.13029320000000003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00325733	0.13029320000000003
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00325733	0.13029320000000003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.00325733	0.13029320000000003
BARATELA-SCOTT SYNDROME	0.00325733	0.13029320000000003
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00325733	0.13029320000000003
COFFIN-SIRIS SYNDROME 10; CSS10	0.00325733	0.13029320000000003
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00325733	0.13029320000000003
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00325733	0.13029320000000003
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00325733	0.13029320000000003
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00325733	0.13029320000000003
Mental retardation, autosomal dominant 21	0.00325733	0.13029320000000003
NOONAN SYNDROME 4; NS4	0.00325733	0.13029320000000003
JACOBSEN SYNDROME	0.00325733	0.13029320000000003
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00325733	0.13029320000000003
PEHO-LIKE SYNDROME; PEHOL	0.00325733	0.13029320000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.00325733	0.13029320000000003
NOONAN SYNDROME 3; NS3	0.00325733	0.13029320000000003
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00325733	0.13029320000000003
CEREBROOCULONASAL SYNDROME	0.00325733	0.13029320000000003
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00325733	0.13029320000000003
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00325733	0.13029320000000003
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00325733	0.13029320000000003
MOEBIUS SYNDROME; MBS	0.00325733	0.13029320000000003
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00325733	0.13029320000000003
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00325733	0.13029320000000003
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00325733	0.13029320000000003
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00325733	0.13029320000000003
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00325733	0.13029320000000003
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.00325733	0.13029320000000003
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00325733	0.13029320000000003
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00325733	0.13029320000000003
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00325733	0.13029320000000003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00325733	0.13029320000000003
EHLERS-DANLOS SYNDROME, TYPE VI	0.00325733	0.13029320000000003
XQ25 DUPLICATION SYNDROME	0.00325733	0.13029320000000003
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00325733	0.13029320000000003
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00325733	0.13029320000000003
RING CHROMOSOME 14 SYNDROME	0.00325733	0.13029320000000003
OHDO SYNDROME	0.00325733	0.13029320000000003
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00325733	0.13029320000000003
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00325733	0.13029320000000003
#278250 WRINKLY SKIN SYNDROME; WSS	0.00325733	0.13029320000000003
PTERYGIUM COLLI, ISOLATED	0.00325733	0.13029320000000003
FRONTONASAL DYSPLASIA 1; FND1	0.00325733	0.13029320000000003
JOUBERT SYNDROME 3; JBTS3	0.00325733	0.13029320000000003
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00325733	0.13029320000000003
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00325733	0.13029320000000003
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00325733	0.13029320000000003
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00325733	0.13029320000000003
#611554 LEOPARD SYNDROME 2	0.00325733	0.13029320000000003
#154780 MARSHALL SYNDROME; MRSHS	0.00325733	0.13029320000000003
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00325733	0.13029320000000003
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00325733	0.13029320000000003
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.00325733	0.13029320000000003
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00325733	0.13029320000000003
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00325733	0.13029320000000003
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00325733	0.13029320000000003
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00325733	0.13029320000000003
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00325733	0.13029320000000003
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00325733	0.13029320000000003
JOUBERT SYNDROME 14	0.00325733	0.13029320000000003
POTOCKI-SHAFFER SYNDROME	0.00325733	0.13029320000000003
Diamond-Blackfan anemia 1	0.00325733	0.13029320000000003
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00325733	0.13029320000000003
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.00325733	0.13029320000000003
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00325733	0.13029320000000003
SCARF SYNDROME	0.00325733	0.13029320000000003
NASODIGITOACOUSTIC SYNDROME	0.00325733	0.13029320000000003
NOONAN SYNDROME 6; NS6	0.00325733	0.13029320000000003
EPICANTHUS	0.00325733	0.13029320000000003
EHLERS-DANLOS SYNDROME, TYPE I	0.00325733	0.13029320000000003
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00325733	0.13029320000000003
BAKER-GORDON SYNDROME; BAGOS	0.00325733	0.13029320000000003
NOONAN SYNDROME 8; NS8	0.00325733	0.13029320000000003
ACROCALLOSAL SYNDROME; ACLS	0.00325733	0.13029320000000003
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00325733	0.13029320000000003
MECKEL SYNDROME, TYPE 10; MKS10	0.00325733	0.13029320000000003
HARTSFIELD SYNDROME; HRTFDS	0.00325733	0.13029320000000003
OROFACIODIGITAL SYNDROME VI	0.00325733	0.13029320000000003
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00325733	0.13029320000000003
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00325733	0.13029320000000003
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00325733	0.13029320000000003
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00325733	0.13029320000000003
BRITTLE CORNEA SYNDROME	0.00325733	0.13029320000000003
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00325733	0.13029320000000003
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00325733	0.13029320000000003
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00325733	0.13029320000000003
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00325733	0.13029320000000003
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00325733	0.13029320000000003
PFEIFFER-PALM-TELLER SYNDROME	0.00325733	0.13029320000000003
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00325733	0.13029320000000003
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00325733	0.13029320000000003
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00325733	0.13029320000000003
#602398 DESMOSTEROLOSIS	0.00325733	0.13029320000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00325733	0.13029320000000003
PHELAN-MCDERMID SYNDROME; PHMDS	0.00325733	0.13029320000000003
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00325733	0.13029320000000003
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00325733	0.13029320000000003
600736 VELOFACIOSKELETAL SYNDROME	0.00325733	0.13029320000000003
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00325733	0.13029320000000003
CHROMOSOME 18Q DELETION SYNDROME	0.00325733	0.13029320000000003
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00325733	0.13029320000000003
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00325733	0.13029320000000003
HADZISELIMOVIC SYNDROME	0.00325733	0.13029320000000003
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00325733	0.13029320000000003
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00325733	0.13029320000000003
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00325733	0.13029320000000003
PEHO SYNDROME; PEHO	0.00325733	0.13029320000000003
HYPOGLOSSIA-HYPODACTYLIA	0.00325733	0.13029320000000003
#300867 KABUKI SYNDROME 2; KABUK2	0.00325733	0.13029320000000003
OROFACIODIGITAL SYNDROME IV; OFD4	0.00325733	0.13029320000000003
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00325733	0.13029320000000003
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.00325733	0.13029320000000003
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00325733	0.13029320000000003
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.00325733	0.13029320000000003
LYMPHEDEMA, HEREDITARY, III	0.00325733	0.13029320000000003
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00325733	0.13029320000000003
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.00325733	0.13029320000000003
ZUNICH NEUROECTODERMAL SYNDROME	0.00325733	0.13029320000000003
JOUBERT SYNDROME 10	0.00325733	0.13029320000000003
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00325733	0.13029320000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.00325733	0.13029320000000003
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.00325733	0.13029320000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.00325733	0.13029320000000003
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.00325733	0.13029320000000003
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00325733	0.13029320000000003
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00325733	0.13029320000000003
CHROMOSOME 13q14 DELETION SYNDROME	0.00325733	0.13029320000000003
MARDEN-WALKER SYNDROME	0.00325733	0.13029320000000003
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00318471	0.12738839999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.00318471	0.12738839999999998
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00318471	0.12738839999999998
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00318471	0.12738839999999998
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00318471	0.12738839999999998
KAGAMI-OGATA SYNDROME	0.00318471	0.12738839999999998
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.00318471	0.12738839999999998
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.00318471	0.12738839999999998
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00318471	0.12738839999999998
GAUCHER DISEASE, TYPE I	0.00318471	0.12738839999999998
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.00318471	0.12738839999999998
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00318471	0.12738839999999998
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00318471	0.12738839999999998
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00318471	0.12738839999999998
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00318471	0.12738839999999998
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00318471	0.12738839999999998
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00318471	0.12738839999999998
APOLIPOPROTEIN C-II DEFICIENCY	0.00318471	0.12738839999999998
PROPIONIC ACIDEMIA	0.00318471	0.12738839999999998
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00318471	0.12738839999999998
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00318471	0.12738839999999998
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00318471	0.12738839999999998
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00318471	0.12738839999999998
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00318471	0.12738839999999998
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00318471	0.12738839999999998
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00318471	0.12738839999999998
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00318471	0.12738839999999998
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00318471	0.12738839999999998
MACROCEPHALY/AUTISM SYNDROME	0.00318471	0.12738839999999998
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.00318471	0.12738839999999998
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.00318471	0.12738839999999998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00318471	0.12738839999999998
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00318471	0.12738839999999998
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00318471	0.12738839999999998
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00318471	0.12738839999999998
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00318471	0.12738839999999998
NIEMANN-PICK DISEASE, TYPE B	0.00318471	0.12738839999999998
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00318471	0.12738839999999998
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00318471	0.12738839999999998
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00318471	0.12738839999999998
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00318471	0.12738839999999998
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00318471	0.12738839999999998
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00318471	0.12738839999999998
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00318471	0.12738839999999998
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00318471	0.12738839999999998
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00318471	0.12738839999999998
GAUCHER DISEASE, TYPE IIIC	0.00318471	0.12738839999999998
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00318471	0.12738839999999998
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00318471	0.12738839999999998
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.00318471	0.12738839999999998
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.00318471	0.12738839999999998
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00318471	0.12738839999999998
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00318471	0.12738839999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.00318471	0.12738839999999998
GAUCHER DISEASE, TYPE II	0.00318471	0.12738839999999998
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00318471	0.12738839999999998
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00318471	0.12738839999999998
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.00318471	0.12738839999999998
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00318471	0.12738839999999998
#614034 HEME OXYGENASE 1 DEFICIENCY; HMOX1D	0.00318471	0.12738839999999998
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00318471	0.12738839999999998
HURLER-SCHEIE SYNDROME	0.00318471	0.12738839999999998
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.00318471	0.12738839999999998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00318471	0.12738839999999998
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00318471	0.12738839999999998
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.00318471	0.12738839999999998
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00318471	0.12738839999999998
HYPERLIPOPROTEINEMIA, TYPE ID	0.00318471	0.12738839999999998
GLUTARIC ACIDEMIA I; GA1	0.00318471	0.12738839999999998
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00318471	0.12738839999999998
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00318471	0.12738839999999998
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00318471	0.12738839999999998
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.00318471	0.12738839999999998
GAPO SYNDROME; GAPOS	0.00318471	0.12738839999999998
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00318471	0.12738839999999998
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.00318471	0.12738839999999998
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00318471	0.12738839999999998
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00318471	0.12738839999999998
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.00318471	0.12738839999999998
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00318471	0.12738839999999998
COMBINED SAPOSIN DEFICIENCY	0.00318471	0.12738839999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00318471	0.12738839999999998
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00318471	0.12738839999999998
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00318471	0.12738839999999998
COCKAYNE SYNDROME A; CSA	0.00318471	0.12738839999999998
TANGIER DISEASE; TGD	0.00318471	0.12738839999999998
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00318471	0.12738839999999998
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.00318471	0.12738839999999998
ROIFMAN SYNDROME; RFMN	0.00318471	0.12738839999999998
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.00318471	0.12738839999999998
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00318471	0.12738839999999998
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00318471	0.12738839999999998
GLYCOGEN STORAGE DISEASE II	0.00318471	0.12738839999999998
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.00318471	0.12738839999999998
AICARDI-GOUTIERES SYNDROME 7	0.00318471	0.12738839999999998
